Go Pro

Tavia Acquisition (TAVI) Competitors

Tavia Acquisition logo
$10.67 +0.02 (+0.19%)
Closing price 03:59 PM Eastern
Extended Trading
$10.65 -0.02 (-0.19%)
As of 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TAVI vs. NOAH, ANGX, BBOT, TRTX, and VINP

Should you buy Tavia Acquisition stock or one of its competitors? MarketBeat compares Tavia Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tavia Acquisition include Noah (NOAH), Angel Studios (ANGX), BridgeBio Oncology Therapeutics (BBOT), TPG RE Finance Trust (TRTX), and Vinci Compass Investments (VINP). These companies are all part of the "trading" industry.

How does Tavia Acquisition compare to Noah?

Noah (NYSE:NOAH) and Tavia Acquisition (NASDAQ:TAVI) are both small-cap trading companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

Noah has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Tavia Acquisition has a beta of 0.01, indicating that its stock price is 99% less volatile than the broader market.

Noah has higher revenue and earnings than Tavia Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noah$373.26M1.62$79.92M$1.088.32
Tavia AcquisitionN/AN/AN/AN/AN/A

42.7% of Noah shares are owned by institutional investors. 47.2% of Noah shares are owned by company insiders. Comparatively, 25.6% of Tavia Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Noah has a net margin of 20.28% compared to Tavia Acquisition's net margin of 0.00%. Noah's return on equity of 5.80% beat Tavia Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Noah20.28% 5.80% 4.91%
Tavia Acquisition N/A N/A N/A

Noah presently has a consensus target price of $10.75, indicating a potential upside of 19.63%. Given Noah's stronger consensus rating and higher probable upside, analysts plainly believe Noah is more favorable than Tavia Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Noah
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Tavia Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Tavia Acquisition had 3 more articles in the media than Noah. MarketBeat recorded 3 mentions for Tavia Acquisition and 0 mentions for Noah. Tavia Acquisition's average media sentiment score of 1.60 beat Noah's score of 0.00 indicating that Tavia Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Noah Neutral
Tavia Acquisition Very Positive

Summary

Noah beats Tavia Acquisition on 9 of the 11 factors compared between the two stocks.

How does Tavia Acquisition compare to Angel Studios?

Angel Studios (NYSE:ANGX) and Tavia Acquisition (NASDAQ:TAVI) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

In the previous week, Angel Studios had 2 more articles in the media than Tavia Acquisition. MarketBeat recorded 5 mentions for Angel Studios and 3 mentions for Tavia Acquisition. Tavia Acquisition's average media sentiment score of 1.60 beat Angel Studios' score of 0.00 indicating that Tavia Acquisition is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Angel Studios
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tavia Acquisition
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

38.6% of Angel Studios shares are owned by institutional investors. 30.1% of Angel Studios shares are owned by company insiders. Comparatively, 25.6% of Tavia Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Angel Studios currently has a consensus price target of $8.50, indicating a potential upside of 105.17%. Given Angel Studios' stronger consensus rating and higher possible upside, equities analysts clearly believe Angel Studios is more favorable than Tavia Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Angel Studios
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
Tavia Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Company Net Margins Return on Equity Return on Assets
Angel StudiosN/A N/A -76.32%
Tavia Acquisition N/A N/A N/A

Tavia Acquisition has lower revenue, but higher earnings than Angel Studios.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Angel Studios$389.22M1.98-$170.48M-$0.75N/A
Tavia AcquisitionN/AN/AN/AN/AN/A

Angel Studios has a beta of -0.01, indicating that its share price is 101% less volatile than the broader market. Comparatively, Tavia Acquisition has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

Summary

Angel Studios beats Tavia Acquisition on 8 of the 11 factors compared between the two stocks.

How does Tavia Acquisition compare to BridgeBio Oncology Therapeutics?

Tavia Acquisition (NASDAQ:TAVI) and BridgeBio Oncology Therapeutics (NASDAQ:BBOT) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

In the previous week, BridgeBio Oncology Therapeutics had 3 more articles in the media than Tavia Acquisition. MarketBeat recorded 6 mentions for BridgeBio Oncology Therapeutics and 3 mentions for Tavia Acquisition. Tavia Acquisition's average media sentiment score of 1.60 beat BridgeBio Oncology Therapeutics' score of 0.54 indicating that Tavia Acquisition is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tavia Acquisition
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
BridgeBio Oncology Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tavia Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market. Comparatively, BridgeBio Oncology Therapeutics has a beta of 0.39, meaning that its share price is 61% less volatile than the broader market.

54.9% of BridgeBio Oncology Therapeutics shares are held by institutional investors. 25.6% of Tavia Acquisition shares are held by insiders. Comparatively, 24.4% of BridgeBio Oncology Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tavia AcquisitionN/AN/AN/AN/AN/A
BridgeBio Oncology TherapeuticsN/AN/A-$134.04M-$2.05N/A

Company Net Margins Return on Equity Return on Assets
Tavia AcquisitionN/A N/A N/A
BridgeBio Oncology Therapeutics N/A N/A N/A

BridgeBio Oncology Therapeutics has a consensus price target of $24.80, indicating a potential upside of 198.44%. Given BridgeBio Oncology Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe BridgeBio Oncology Therapeutics is more favorable than Tavia Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tavia Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
BridgeBio Oncology Therapeutics
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

BridgeBio Oncology Therapeutics beats Tavia Acquisition on 6 of the 8 factors compared between the two stocks.

How does Tavia Acquisition compare to TPG RE Finance Trust?

TPG RE Finance Trust (NYSE:TRTX) and Tavia Acquisition (NASDAQ:TAVI) are both small-cap trading companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

TPG RE Finance Trust has a net margin of 19.38% compared to Tavia Acquisition's net margin of 0.00%. TPG RE Finance Trust's return on equity of 6.91% beat Tavia Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
TPG RE Finance Trust19.38% 6.91% 1.74%
Tavia Acquisition N/A N/A N/A

TPG RE Finance Trust currently has a consensus price target of $9.83, suggesting a potential upside of 12.32%. Given TPG RE Finance Trust's stronger consensus rating and higher probable upside, equities research analysts clearly believe TPG RE Finance Trust is more favorable than Tavia Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TPG RE Finance Trust
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Tavia Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

TPG RE Finance Trust has higher revenue and earnings than Tavia Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TPG RE Finance Trust$151.45M4.47$60.32M$0.6313.90
Tavia AcquisitionN/AN/AN/AN/AN/A

In the previous week, Tavia Acquisition had 2 more articles in the media than TPG RE Finance Trust. MarketBeat recorded 3 mentions for Tavia Acquisition and 1 mentions for TPG RE Finance Trust. TPG RE Finance Trust's average media sentiment score of 1.80 beat Tavia Acquisition's score of 1.60 indicating that TPG RE Finance Trust is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TPG RE Finance Trust
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Tavia Acquisition
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

57.1% of TPG RE Finance Trust shares are owned by institutional investors. 3.0% of TPG RE Finance Trust shares are owned by insiders. Comparatively, 25.6% of Tavia Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

TPG RE Finance Trust has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, Tavia Acquisition has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market.

Summary

TPG RE Finance Trust beats Tavia Acquisition on 10 of the 12 factors compared between the two stocks.

How does Tavia Acquisition compare to Vinci Compass Investments?

Vinci Compass Investments (NASDAQ:VINP) and Tavia Acquisition (NASDAQ:TAVI) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

34.1% of Vinci Compass Investments shares are owned by institutional investors. 49.3% of Vinci Compass Investments shares are owned by insiders. Comparatively, 25.6% of Tavia Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Vinci Compass Investments had 4 more articles in the media than Tavia Acquisition. MarketBeat recorded 7 mentions for Vinci Compass Investments and 3 mentions for Tavia Acquisition. Tavia Acquisition's average media sentiment score of 1.60 beat Vinci Compass Investments' score of 0.88 indicating that Tavia Acquisition is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vinci Compass Investments
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tavia Acquisition
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Vinci Compass Investments has higher revenue and earnings than Tavia Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vinci Compass Investments$1.02B0.63$38.97M$0.7413.34
Tavia AcquisitionN/AN/AN/AN/AN/A

Vinci Compass Investments presently has a consensus price target of $14.00, indicating a potential upside of 41.84%. Given Vinci Compass Investments' stronger consensus rating and higher probable upside, analysts plainly believe Vinci Compass Investments is more favorable than Tavia Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vinci Compass Investments
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Tavia Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Vinci Compass Investments has a net margin of 26.75% compared to Tavia Acquisition's net margin of 0.00%. Vinci Compass Investments' return on equity of 13.73% beat Tavia Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Vinci Compass Investments26.75% 13.73% 7.32%
Tavia Acquisition N/A N/A N/A

Vinci Compass Investments has a beta of 0.29, suggesting that its stock price is 71% less volatile than the broader market. Comparatively, Tavia Acquisition has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

Summary

Vinci Compass Investments beats Tavia Acquisition on 11 of the 12 factors compared between the two stocks.

Get Tavia Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAVI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TAVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TAVI vs. The Competition

MetricTavia AcquisitionInvestment Offices IndustryFinancial SectorNASDAQ Exchange
Market Cap$169.88M$292.22M$6.20B$12.45B
Dividend YieldN/AN/A5.24%9.44%
P/E RatioN/A2.1130.0624.25
Price / SalesN/A18,697.761,776.1287.37
Price / CashN/A136.03114.2060.03
Price / BookN/A353.416.536.23
Net IncomeN/A-$66.54M$1.13B$331.94M
7 Day Performance-1.29%-0.82%0.04%-1.93%
1 Month Performance-0.04%-0.68%0.05%-0.97%
1 Year Performance4.00%2.58%15.52%18.24%

Tavia Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TAVI
Tavia Acquisition
1.5868 of 5 stars
$10.67
+0.2%
N/A+5.4%$169.88MN/AN/A2
NOAH
Noah
4.6754 of 5 stars
$10.31
+2.8%
$10.75
+4.3%
-24.1%$676.49M$373.26M9.551,778
ANGX
Angel Studios
3.4476 of 5 stars
$3.53
-0.4%
$8.50
+141.1%
N/A$659.90M$321.56MN/AN/A
BBOT
BridgeBio Oncology Therapeutics
3.064 of 5 stars
$8.41
+3.7%
$24.25
+188.3%
N/A$649.67MN/AN/AN/A
TRTX
TPG RE Finance Trust
3.7258 of 5 stars
$8.35
-0.6%
$9.83
+17.8%
+6.5%$649.39M$332.58M13.25N/A

Related Companies and Tools


This page (NASDAQ:TAVI) was last updated on 7/16/2026 by MarketBeat.com Staff.
From Our Partners